15 years of historical data (2011–2025) · Healthcare · Medical - Diagnostics & Research
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
IQVIA Holdings Inc. trades at 21.4x earnings, 40% below its 5-year average of 35.9x, sitting at the 8th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x. On a free-cash-flow basis, the stock trades at 13.9x P/FCF, 39% below the 5-year average of 22.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $28.5B | $39.1B | $36.0B | $43.1B | $39.1B | $55.0B | $34.9B | $30.8B | $24.2B | $21.8B | $11.6B |
| Enterprise Value | $42.7B | $53.3B | $48.5B | $55.6B | $50.8B | $66.1B | $46.0B | $42.0B | $34.3B | $31.1B | $17.6B |
| P/E Ratio → | 21.40 | 28.75 | 26.24 | 31.74 | 35.82 | 57.00 | 125.29 | 160.95 | 93.69 | 16.65 | 100.07 |
| P/S Ratio | 1.75 | 2.40 | 2.34 | 2.88 | 2.71 | 3.97 | 3.08 | 2.78 | 2.32 | 2.25 | 1.70 |
| P/B Ratio | 4.39 | 5.90 | 5.94 | 7.05 | 6.77 | 9.11 | 5.56 | 4.92 | 3.48 | 2.61 | 1.30 |
| P/FCF | 13.88 | 19.07 | 17.05 | 28.74 | 24.62 | 23.90 | 26.02 | 36.93 | 30.42 | 36.26 | 16.61 |
| P/OCF | 10.73 | 14.74 | 13.27 | 20.06 | 17.28 | 18.70 | 17.83 | 21.76 | 19.29 | 22.47 | 13.44 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
IQVIA Holdings Inc.'s enterprise value stands at 12.4x EBITDA, 31% below its 5-year average of 18.1x. The Healthcare sector median is 14.2x, placing the stock at a 13% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.27 | 3.15 | 3.71 | 3.53 | 4.76 | 4.05 | 3.79 | 3.29 | 3.20 | 2.58 |
| EV / EBITDA | 12.44 | 15.54 | 14.62 | 17.93 | 17.36 | 24.87 | 22.81 | 21.25 | 18.23 | 17.95 | 18.86 |
| EV / EBIT | 18.66 | 22.98 | 20.73 | 26.10 | 28.58 | 43.97 | 58.34 | 52.62 | 46.23 | 48.53 | 31.36 |
| EV / FCF | — | 25.99 | 22.94 | 37.08 | 32.06 | 28.71 | 34.27 | 50.35 | 43.15 | 51.68 | 25.23 |
Margins and return-on-capital ratios measuring operating efficiency
IQVIA Holdings Inc. earns an operating margin of 14.0%. ROE of 21.4% indicates solid capital efficiency. ROIC of 8.7% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.3% | 26.3% | 34.9% | 35.0% | 34.9% | 33.5% | 34.0% | 34.2% | 35.2% | 35.1% | 30.3% |
| Operating Margin | 14.0% | 14.0% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 7.4% | 9.4% |
| Net Profit Margin | 8.3% | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.5% | 1.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.4% | 21.4% | 22.5% | 22.9% | 18.5% | 15.7% | 4.4% | 2.9% | 3.4% | 15.2% | 2.6% |
| ROA | 4.8% | 4.8% | 5.1% | 5.2% | 4.4% | 3.9% | 1.2% | 0.8% | 1.1% | 6.0% | 0.9% |
| ROIC | 8.7% | 8.7% | 8.9% | 8.2% | 7.8% | 6.1% | 3.1% | 3.4% | 3.2% | 3.3% | 5.9% |
| ROCE | 11.0% | 11.0% | 11.0% | 9.9% | 9.2% | 7.1% | 3.7% | 4.1% | 3.8% | 3.8% | 6.2% |
Solvency and debt-coverage ratios — lower is generally safer
IQVIA Holdings Inc. carries a Debt/EBITDA ratio of 4.7x, which is highly leveraged (47% above the sector average of 3.2x). Net debt stands at $14.2B ($16.2B total debt minus $2.0B cash). Interest coverage of 3.2x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.44 | 2.44 | 2.33 | 2.27 | 2.26 | 2.06 | 2.05 | 1.92 | 1.58 | 1.22 | 0.81 |
| Debt / EBITDA | 4.71 | 4.71 | 4.27 | 4.48 | 4.44 | 4.68 | 6.39 | 6.08 | 5.85 | 5.91 | 7.73 |
| Net Debt / Equity | — | 2.14 | 2.05 | 2.05 | 2.05 | 1.83 | 1.77 | 1.79 | 1.45 | 1.11 | 0.68 |
| Net Debt / EBITDA | 4.14 | 4.14 | 3.76 | 4.04 | 4.03 | 4.17 | 5.50 | 5.66 | 5.38 | 5.36 | 6.45 |
| Debt / FCF | — | 6.92 | 5.89 | 8.35 | 7.44 | 4.81 | 8.26 | 13.42 | 12.72 | 15.42 | 8.62 |
| Interest Coverage | 3.18 | 3.18 | 3.49 | 3.17 | 4.28 | 4.01 | 1.90 | 1.79 | 1.79 | 1.85 | 3.89 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.75x is below 1.0, meaning current liabilities exceed current assets — though the company's $2.0B cash position helps mitigate short-term liquidity concerns. The current ratio has declined from 0.86x to 0.75x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | 0.75 | 0.84 | 0.86 | 0.89 | 0.91 | 1.12 | 1.05 | 1.10 | 1.22 | 1.23 |
| Quick Ratio | 0.75 | 0.75 | 0.84 | 0.86 | 0.89 | 0.91 | 1.12 | 1.05 | 1.10 | 1.22 | 1.23 |
| Cash Ratio | 0.26 | 0.26 | 0.26 | 0.23 | 0.23 | 0.28 | 0.42 | 0.23 | 0.27 | 0.35 | 0.46 |
| Asset Turnover | — | 0.54 | 0.57 | 0.56 | 0.57 | 0.56 | 0.46 | 0.48 | 0.46 | 0.43 | 0.32 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 76.69 | 76.77 | 83.14 | 74.98 | 68.64 | 79.24 | 86.84 | 86.34 | 80.66 | 93.25 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
IQVIA Holdings Inc. returns 4.4% to shareholders annually primarily through share buybacks. The earnings yield of 4.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.7% | 3.5% | 3.8% | 3.2% | 2.8% | 1.8% | 0.8% | 0.6% | 1.1% | 6.0% | 1.0% |
| FCF Yield | 7.2% | 5.2% | 5.9% | 3.5% | 4.1% | 4.2% | 3.8% | 2.7% | 3.3% | 2.8% | 6.0% |
| Buyback Yield | 4.4% | 3.2% | 3.7% | 2.3% | 3.0% | 0.7% | 1.3% | 3.1% | 5.8% | 12.0% | 9.5% |
| Total Shareholder Yield | 4.4% | 3.2% | 3.7% | 2.3% | 3.0% | 0.7% | 1.3% | 3.1% | 5.8% | 12.0% | 9.5% |
| Shares Outstanding | — | $174M | $183M | $186M | $191M | $195M | $195M | $200M | $208M | $223M | $152M |
Compare IQV with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $28B | 21.4 | 12.4 | 13.9 | 26.3% | 14.0% | 21.4% | 8.7% | 4.7 | |
| $9B | -63.6 | 12.9 | 17.2 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 | |
| $11B | 50.3 | 10.1 | 13.0 | 26.4% | 12.3% | 2.5% | 6.2% | 2.5 | |
| $1B | 24.9 | 19.5 | — | 39.4% | 6.6% | 4.0% | 3.2% | 5.1 | |
| $13B | 30.1 | 22.9 | 19.3 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 | |
| $25B | 28.2 | 19.7 | 18.0 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 | |
| $20B | 15.3 | 11.6 | 14.5 | 91.5% | 26.1% | 29.9% | 51.1% | 0.0 | |
| $20B | -95.4 | — | 56.1 | 69.7% | -6.4% | -8.7% | -3.6% | — | |
| $129M | -0.7 | 17.3 | — | 33.5% | -11.6% | -58.3% | -6.1% | 11.9 | |
| $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 15 years · Updated daily
Deep dive into IQV consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IQV stock.
IQVIA Holdings Inc.'s current P/E ratio is 21.4x. The historical average is 57.4x. This places it at the 8th percentile of its historical range.
IQVIA Holdings Inc.'s current EV/EBITDA is 12.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.5x.
IQVIA Holdings Inc.'s return on equity (ROE) is 21.4%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 13.0%.
Based on historical data, IQVIA Holdings Inc. is trading at a P/E of 21.4x. This is at the 8th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
IQVIA Holdings Inc. has 26.3% gross margin and 14.0% operating margin. Operating margin between 10-20% is typical for established companies.
IQVIA Holdings Inc.'s Debt/EBITDA ratio is 4.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.